ArticleCancer biology & therapy2018

A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.